Practical Management of Enfortumab Vedotin Plus Pembrolizumab in Advanced Urothelial Carcinoma.
- DOI
- 10.1590/s1677-5538.ibju.2026.9917
- Published
- 2027 Jan-Feb
- Container
- International braz j urol : official journal of the Brazilian Society of Urology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1590/s1677-5538.ibju.2026.9917,
title = {Practical Management of Enfortumab Vedotin Plus Pembrolizumab in Advanced Urothelial Carcinoma.},
author = {Carron J and de Moraes AAJG and Sasse AD and Reis LO},
year = {2027},
journal = {International braz j urol : official journal of the Brazilian Society of Urology},
doi = {10.1590/s1677-5538.ibju.2026.9917},
url = {https://doi.org/10.1590/s1677-5538.ibju.2026.9917}
}RIS
TY - JOUR TI - Practical Management of Enfortumab Vedotin Plus Pembrolizumab in Advanced Urothelial Carcinoma. AU - Carron J AU - de Moraes AAJG AU - Sasse AD AU - Reis LO PY - 2027 JO - International braz j urol : official journal of the Brazilian Society of Urology DO - 10.1590/s1677-5538.ibju.2026.9917 UR - https://doi.org/10.1590/s1677-5538.ibju.2026.9917 ER -
APA
J, C., AAJG, D. M., AD, S., & LO, R. (2027). Practical Management of Enfortumab Vedotin Plus Pembrolizumab in Advanced Urothelial Carcinoma.. International braz j urol : official journal of the Brazilian Society of Urology. https://doi.org/10.1590/s1677-5538.ibju.2026.9917
Source records
- pubmed · retrieved 2026-11-10T20:35:26.207Z